Allergy Immunotherapy Market

Allergy Immunotherapy Market (Treatment Type - Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT); Allergy Type - Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy; Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL35708
  • Published On : Apr 2018
  • No. of Pages : 191
  • Category : Pharmaceutical

Chapter 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2 Assumptions and Research Methodology

Chapter 3 Executive Summary: Global Allergy Immunotherapy Market

Chapter 4 Market Overview
4.1. Introduction
4.2. Key Industry Developments

Chapter 5 Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
5.5. Global Allergy Immunotherapy Market Outlook

Chapter 6 Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment Type
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       6.3.1. Subcutaneous Immunotherapy (SCIT)
       6.3.2. Sublingual Immunotherapy(SLIT)
6.4. Market Attractiveness Analysis, by Treatment Type

Chapter 7 Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
7.1. Key Findings
7.2. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
       7.2.1. Allergic Rhinitis
       7.2.2. Asthma
       7.2.3. Food Allergy
       7.2.4. Venom Allergy
       7.2.5. Others
7.3. Market Attractiveness Analysis, by Allergy Type
7.4. Key Trends

Chapter 8 Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
       8.3.1. Hospital Pharmacy
       8.3.2. Retail Pharmacy and Drug Stores
       8.3.3. Online Pharmacy
8.4. Market Attractiveness Analysis, by Distribution Channel

Chapter 9 Global Allergy Immunotherapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Market Scenario
9.3. Market Value (US$ Mn) Forecast, by Region, 2017–2025
       9.3.1. North America
       9.3.2. Europe
       9.3.3. Asia Pacific
       9.3.4. Latin America
       9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region

Chapter 10 North America Allergy Immunotherapy Market Analysis and Forecast
10.1. Key Findings
10.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       10.2.1. U.S.
       10.2.2. Canada
10.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       10.3.1. SCIT
       10.3.2. SLIT
10.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
       10.4.1. Allergic Rhinitis
       10.4.2. Asthma
       10.4.3. Food Allergy
       10.4.4. Venom Allergy
       10.4.5. Other
10.5. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
       10.5.1. Hospital Pharmacy
       10.5.2. Retail Pharmacy and Drug Stores
       10.5.3. Online Pharmacy
10.6. Market Attractiveness Analysis
       10.6.1. By Country
       10.6.2. By Treatment Type
       10.6.3. By Allergy Type
       10.6.4. By Distribution Channel

Chapter 11 Europe Allergy Immunotherapy Market Analysis and Forecast
11.1. Key Findings
11.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
       11.2.1. Germany
       11.2.2. U.K.
       11.2.3. France
       11.2.4. Italy
       11.2.5. Spain
       11.2.6. Russia
       11.2.7. Rest of Europe
11.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       11.3.1. SCIT
       11.3.2. SLIT
11.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
       11.4.1. Allergic Rhinitis
       11.4.2. Asthma
       11.4.3. Food Allergy
       11.4.4. Venom Allergy
       11.4.5. Others
11.5. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
       11.5.1. Hospital Pharmacy
       11.5.2. Retail Pharmacy and Drug Stores
       11.5.3. Online Pharmacy
11.6. Market Attractiveness Analysis
       11.6.1. By Country
       11.6.2. By Treatment Type
       11.6.3. By Allergy Type
       11.6.4. By Distribution Channel

Chapter 12 Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
12.1. Key Findings / Developments
12.2. Market Overview
12.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
       12.3.1. China
       12.3.2. India
       12.3.3. Japan
       12.3.4. Australia & New Zealand
       12.3.5. Rest of Asia Pacific
12.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       12.4.1. SCIT
       12.4.2. SLIT
12.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
       12.5.1. Allergic Rhinitis
       12.5.2. Asthma
       12.5.3. Food Allergy
       12.5.4. Venom Allergy
       12.5.5. Others
12.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
       12.6.1. Hospital Pharmacy
       12.6.2. Retail Pharmacy and Drug Stores
       12.6.3. Online Pharmacy
12.7. Market Attractiveness Analysis
       12.7.1. By Country
       12.7.2. By Treatment Type
       12.7.3. By Allergy Type
       12.7.4. By Distribution Channel

Chapter 13 Latin America Allergy Immunotherapy Market Analysis and Forecast
13.1. Key Findings / Developments
13.2. Market Overview
13.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
       13.3.1. Brazil
       13.3.2. Mexico
       13.3.3. Rest of Latin America
13.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       13.4.1. SCIT
       13.4.2. SLIT
13.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017-2025
       13.5.1. Allergic Rhinitis
       13.5.2. Asthma
       13.5.3. Food Allergy
       13.5.4. Venom Allergy
       13.5.5. Others
13.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
       13.6.1. Hospital Pharmacy
       13.6.2. Retail Pharmacy and Drug Stores
       13.6.3. Online Pharmacy
13.7. Market Attractiveness Analysis
       13.7.1. By Country/Sub-region
       13.7.2. By Treatment Type
       13.7.3. By Allergy Type
       13.7.4. By Distribution Channel

Chapter 14 Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
14.1. Key Findings / Developments
14.2. Market Overview
14.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
       14.3.1. GCC Countries
       14.3.2. South Africa
       14.3.3. Israel
       14.3.4. Rest of Middle East & Africa
14.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
       14.4.1. SCIT
       14.4.2. SLIT
14.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
       14.5.1. Allergic Rhinitis
       14.5.2. Asthma
       14.5.3. Food Allergy
       14.5.4. Venom Allergy
       14.5.5. Others
14.6. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
       14.6.1. Hospital Pharmacy
       14.6.2. Retail Pharmacy and Drug Stores
       14.6.3. Online Pharmacy
14.7. Market Attractiveness Analysis
       14.7.1. By Country/Sub-region
       14.7.2. By Treatment Type
       14.7.3. By Allergy Type
       14.7.4. By Distribution Channel

Chapter 15 Pipeline Analysis
       15.1.1. Allergy Immunotherapy Pipeline Analysis (2017)

Chapter 16 Allergy Immunotherapy – Regulatory Overview
       16.1.1. Regulatory Status for European Union
       16.1.2. Regulatory Status for U.S.

Chapter 17 Competition Landscape
17.1. Global Allergy Immunotherapy Market Share, by Company, 2017
17.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
       17.2.1. ALK-Abello A/S
                 17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.1.2. Product Portfolio
                 17.2.1.3. SWOT Analysis
                 17.2.1.4. Strategic Overview
       17.2.2. Allergy Therapeutics
                 17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.2.2. Product Portfolio
                 17.2.2.3. SWOT Analysis
                 17.2.2.4. Strategic Overview
       17.2.3. Stallergenes Greer
                 17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.3.2. Product Portfolio
                 17.2.3.3. SWOT Analysis
                 17.2.3.4. Financial Overview
                 17.2.3.5. Strategic Overview
       17.2.4. HAL Allergy Group
                 17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.4.2. Product Portfolio
                 17.2.4.3. SWOT Analysis
                 17.2.4.4. Financial Overview
                 17.2.4.5. Strategic Overview
       17.2.5. DBV Technologies
                 17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.5.2. Product Portfolio
                 17.2.5.3. SWOT Analysis
                 17.2.5.4. Financial Overview
                 17.2.5.5. Strategic Overview
       17.2.6. Merck KGaA
                 17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.6.2. Product Portfolio
                 17.2.6.3. SWOT Analysis
                 17.2.6.4. Financial Overview
                 17.2.6.5. Strategic Overview
       17.2.7. Aimmune Therapeutics
                 17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.7.2. Product Portfolio
                 17.2.7.3. SWOT Analysis
                 17.2.7.4. Financial Overview
                 17.2.7.5. Strategic Overview
       17.2.8. Circassia
                 17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.8.2. Product Portfolio
                 17.2.8.3. SWOT Analysis
                 17.2.8.4. Financial Overview
                 17.2.8.5. Strategic Overview
       17.2.9. Anergis
                 17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.9.2. Product Portfolio
                 17.2.9.3. SWOT Analysis
                 17.2.9.4. Financial Overview
                 17.2.9.5. Strategic Overview
       17.2.10. Biomay AG
                 17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                 17.2.10.2. Product Portfolio
                 17.2.10.3. SWOT Analysis
                 17.2.10.4. Financial Overview
                 17.2.10.5. Strategic Overview

List of Tables

Table 01: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 02: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 03: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 04: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 06: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel , 2015–2025
Table 07: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 08: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 10: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 11: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 13: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 14: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 15: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Types, 2015–2025
Table 18: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 19: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 20: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 22: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 23: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
Table 24: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

List of Figures

Figure 01: Market Snapshot 
Figure 02: Market Value Share By Treatment Type (2017) Value (US$ Mn)
Figure 03: Market Value Share By Allergy Type (2017) Value (US$ Mn)
Figure 04: Market Value Share By Distribution Channel (2017) Value (US$ Mn)
Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Type, 2016 and 2025
Figure 06: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SCIT, 2015–2025
Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SLIT, 2015–2025
Figure 8: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 09: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 10: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2015–2025
Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2015–2025
Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies and Drug Store, 2015–2025
Figure 13: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 14: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinitis, 2015–2025
Figure 16: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2015–2025
Figure 17: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food Allergy, 2015–2025
Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Venom Allergy, 2015–2025
Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2027
Figure 20: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type , 2017–2025
Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2016 and 2025
Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2017–2025
Figure 23: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 24: North America Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
Figure 25: North America Allergy Immunotherapy Market Attractiveness, by Country, 2017–2025
Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 30: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 32: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2016 and 2025
Figure 33: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 34: Europe Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
Figure 35: Europe Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 36: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 37: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 38: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 39: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 40: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 41: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 42: Europe Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 43: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 44: Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 50: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 52: Asia Pacific Surgical Drapes Market, by Country, 2016 and 2025
Figure 53: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 54: Latin America Allergy Immunotherapy Y-o-Y Growth Projections, 2016–2025
Figure 55: Latin America Allergy Immunotherapy Market Attractiveness, by Country, 2016
Figure 56: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 57: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 58: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 59: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 60: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 61: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 62: Latin America Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 63: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
Figure 64: Middle East & Africa Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
Figure 65: Middle East & Africa Allergy Immunotherapy Market Attractiveness, by Country, 2017-2025
Figure 66: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
Figure 67: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
Figure 68: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
Figure 69: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
Figure 70: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 71: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 72: Middle East & Africa Allergy Immunotherapy Market, by Country, 2016 and 2025
Figure 73: Global Allergy Therapeutics Market Share Analysis, by Company (2017)
Figure 74: ALK-Abello A/S Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 75: ALK-Abello A/S Global Operating Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 76: ALK-Abello A/S Breakdown of Net Sales, by Region, 2017
Figure 77: ALK-Abello A/S Breakdown of Net Sales, by Business Segment, 2017
Figure 78: Allergy Therapeutics Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 79: Allergy Therapeutics Breakdown of Net Sales, by Region, 2017
Figure 80: Allergy Therapeutics Breakdown of Net Sales, by Business Segment, 2017
Figure 81: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
Figure 82: Stallergenes Greer R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 83: Stallergenes Greer Breakdown of Net Sales, by Region, 2017
Figure 84: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
Figure 85: Merck KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 86: Merck KGaA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 87: Merck KGaA Breakdown of Net Sales, by Region, 2017
Figure 88: Merck KGaA Breakdown of Net Sales, by Business Segment, 2017
Figure 89: Circassia Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 90: Circassia Global Research and Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016

.